skip to main content
DOE Patents title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Cellulose binding domain proteins

Abstract

A cellulose binding domain (CBD) having a high affinity for crystalline cellulose and chitin is disclosed, along with methods for the molecular cloning and recombinant production. Fusion products comprising the CBD and a second protein are likewise described. A wide range of applications are contemplated for both the CBD and the fusion products, including drug delivery, affinity separations, and diagnostic techniques. 16 figs.

Inventors:
; ; ;
Issue Date:
Research Org.:
Univ. of California (United States)
Sponsoring Org.:
USDOE, Washington, DC (United States)
OSTI Identifier:
675819
Patent Number(s):
5837814
Application Number:
PAN: 8-460,455
Assignee:
Yissum Research Development Co., Jerusalem (Israel); Univ. of California, Davis, CA (United States)
DOE Contract Number:  
FG03-92ER20069
Resource Type:
Patent
Resource Relation:
Other Information: PBD: 17 Nov 1998
Country of Publication:
United States
Language:
English
Subject:
55 BIOLOGY AND MEDICINE, BASIC STUDIES; CELLULOSE; AFFINITY; PROTEINS; DRUGS; DIAGNOSTIC TECHNIQUES; CHEMICAL BONDS

Citation Formats

Shoseyov, O, Shpiegl, I, Goldstein, M, and Doi, R. Cellulose binding domain proteins. United States: N. p., 1998. Web.
Shoseyov, O, Shpiegl, I, Goldstein, M, & Doi, R. Cellulose binding domain proteins. United States.
Shoseyov, O, Shpiegl, I, Goldstein, M, and Doi, R. Tue . "Cellulose binding domain proteins". United States.
@article{osti_675819,
title = {Cellulose binding domain proteins},
author = {Shoseyov, O and Shpiegl, I and Goldstein, M and Doi, R},
abstractNote = {A cellulose binding domain (CBD) having a high affinity for crystalline cellulose and chitin is disclosed, along with methods for the molecular cloning and recombinant production. Fusion products comprising the CBD and a second protein are likewise described. A wide range of applications are contemplated for both the CBD and the fusion products, including drug delivery, affinity separations, and diagnostic techniques. 16 figs.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {1998},
month = {11}
}